Key result
Antihypertensive regimen intensification and adherence show no association with blood pressure control or lipid profiles.
Why the study?
Hypertension is highly prevalent in Indonesia and frequently coexists with dyslipidemia, motivating an evaluation of how antihypertensive regimen intensification and treatment adherence relate to blood pressure control and lipid profiles.
Does the intensification of antihypertensive regimens and therapeutic adherence correlate with blood pressure control and lipid profiles in patients with chronic hypertension?
Cohort (n=100)
No
Does the intensification of antihypertensive regimens and therapeutic adherence correlate with blood pressure control and lipid profiles in patients with chronic hypertension?
In this retrospective cohort of 100 chronic hypertension patients in Indonesia, no statistical correlation was detected between antihypertensive therapy intensification or adherence and blood pressure or lipid levels, attributable to a ceiling effect where 100% of the cohort was already adherent and had controlled blood pressure.
Answers are grounded in this paper and cite their sources.
Absence of correlation reflects ceiling effect in controlled cohort; leaves open intensification value in uncontrolled hypertension.
Hypertension is a major public health issue with a high prevalence in Indonesia and is often accompanied by dyslipidemia, which increases cardiovascular risk. This study aims to analyze the relationship between the intensification of antihypertensive regimens and treatment adherence, and their effects on blood pressure control and lipid profiles in patients with chronic hypertension at Ben Mboi General Hospital in Kupang. The subjects were predominantly female (61%) and under 60 years old (66%). The study used a retrospective cohort design based on medical record data of chronic hypertension patients from January to December 2025 and The research sample consisted of 100 patients. All subjects (100%) were classified as compliant with a mean Medication Possession Ratio (MPR) of 0.84±0.02; 88% of patients received therapy intensification (mean Therapeutic Intensity Score 0.08±0.27). The mean blood pressure was 128.00 ± 1.64/79.86 ± 2.12 mmHg, and all subjects had their blood pressure under control. Meanwhile, 12% of subjects had cholesterol levels within the normal range, and all subjects had triglyceride levels within the normal range. The Spearman test showed no significant relationship between MPR or TIS and systolic blood pressure, diastolic blood pressure, total cholesterol, and triglycerides (p-values ranged from 0.340 to 0.808). There was no significant relationship between adherence and therapy intensification and blood pressure control or lipid profiles, likely due to a ceiling effect, as all subjects were already in a controlled condition. The ceiling effect occurs when nearly all subjects fall into the same category for both variables (100% compliant and 100% controlled), resulting in very low data variability that prevents the correlation test from detecting a relationship, regardless of whether such a relationship exists clinically.
No takes yet. Share an insight, caveat, or question.
Wijaya et al. (2026) conducted a cohort in Chronic hypertension (n=100). Antihypertensive regimen intensification and treatment adherence was evaluated on Blood pressure control and lipid profiles (systolic blood pressure, diastolic blood pressure, total cholesterol, and triglycerides) (p=0.340 to 0.808). Antihypertensive therapy intensification and adherence showed no significant correlation with blood pressure control or lipid profiles.
Synapse has enriched 10 related papers. Consider them for comparative context: